title: Ozenoxacin Cream, 1% - Topical Treatment of Impetigo.
authors.affiliation: Department of Medicine, University of Toronto School of Medicine, Toronto, Ontario, Canada, Dallas, TX; agupta@execulink.com.|Mediprobe Research Inc., London, Ontario, Canada, Dallas, TX.
authors.forename: Aditya K
authors.initials: AK
authors.lastname: Gupta
authors.affiliation: Mediprobe Research Inc., London, Ontario, Canada, Dallas, TX.
authors.forename: Sarah G
authors.initials: SG
authors.lastname: Versteeg
authors.affiliation: Department of Medicine, Baylor University Medical Center, Dallas, TX.|Departments of Dermatology and Family Practice, University of Texas Southwestern Medical School, Dallas, TX.|Dermatology Treatment and Research Center, Dallas, TX.
authors.forename: William
authors.initials: W
authors.lastname: Abramovits
mesh_terms: D000287:Administration, Topical; D000328:Adult; D000631:Aminopyridines / Q000627:therapeutic use*; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007169:Impetigo / Q000175:diagnosis* / Q000188:drug therapy*; D008297:Male; D009824:Ointments / Q000008:administration & dosage; D015363:Quinolones / Q000627:therapeutic use*; D012720:Severity of Illness Index; D016896:Treatment Outcome
chemical_list: D000631:Aminopyridines; D000900:Anti-Bacterial Agents; D009824:Ointments; D015363:Quinolones; C000592413:ozenoxacin